Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Abstract Background Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (MBI) leverages behavioral change. Adding MBI to MCI improves dementia pr...

Full description

Bibliographic Details
Main Authors: Zahinoor Ismail, Rebeca Leon, Byron Creese, Clive Ballard, Philippe Robert, Eric E. Smith
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Molecular Neurodegeneration
Subjects:
Alzheimer’s disease
Mild cognitive impairment
Prodromal disease
Neuropsychiatric symptoms
Mild behavioral impairment
Biomarkers
Online Access:https://doi.org/10.1186/s13024-023-00631-6

Internet

https://doi.org/10.1186/s13024-023-00631-6

Similar Items